Surgical Science Sweden
Surgical Science Sweden AB develops medical simulation solutions used to train surgeons and other healthcare professionals in minimally invasive procedures. The company is headquartered in Gothenburg, Sweden, and operates through an international footprint with offices and sales presence in the US, the UK, China, Israel, and Sweden.
Fiscal year 2025 · change from previous year
Development 2022–2025
Business
Share of revenueDigital simulation platforms used to train clinicians in surgical techniques and workflows.
Physical simulator systems and devices used for hands-on procedural training.
Simulation tools focused on robotic-assisted surgery training and certification.
Simulation products for ultrasound education and clinical skills development.
Customers
Customers are primarily hospitals, medical schools, training centers, and healthcare organizations that need objective, repeatable surgical training. The company also sells to OEMs and technology partners in the surgical robotics ecosystem, where simulation is used for product training, adoption, and certification. Demand is driven by the need for safer training, standardized credentialing, and broader use of simulation in clinical education.
Buy simulators and training platforms to train surgeons and staff before procedures.
Purchase simulation systems for education, skills practice, and curriculum support.
Use simulation products to support training, onboarding, and certification around robotic systems.
Acquire software and services for standardized procedural training and assessment.
Buy ultrasound simulation tools for clinical skills development and training programs.
Strategy
Surgical Science’s strategy centers on making simulation a standard part of healthcare training and certification. The company is focused on organic growth, selective acquisitions, and building a stronger position across its core market segments, while expanding its commercial footprint in key regions. The strategy also emphasizes disciplined execution, targeted investment in expertise, and broader adoption of simulation in robotics and other surgical workflows.
Higher penetration supports long-term demand for training platforms and recurring customer relationships.
These areas connect the company to fast-evolving surgical workflows and OEM ecosystems.
Acquisitions can add products, customers, and geographic reach faster than organic growth alone.
Simulation sales and support are relationship-driven and often require local implementation capability.
Geography
Surgical Science is headquartered in Sweden but operates internationally through offices in the US, the UK, China, and Israel. The company’s operating footprint matters because sales, support, and implementation are closely tied to local healthcare customers and training institutions. Its revenue and cost base are exposed to several currencies, especially USD, ILS, EUR, and GBP.
Risks
The business depends on long sales cycles, customer adoption of simulation, and continued demand from healthcare institutions and OEM partners. It is also exposed to currency swings, tariff-related costs, integration risk from acquisitions, and concentration risk around large customers and key markets. As a medical training company, it faces industry risks tied to regulation, procurement cycles, and the pace at which healthcare systems adopt simulation-based training.
- Long sales cyclesImpact: High
Orders can take months to close, delaying revenue recognition and cash conversion.
Exposure: Enterprise and institutional sales
- Customer concentrationImpact: High
A large customer or partner can materially affect demand if purchasing patterns change.
Exposure: Large OEM and healthcare accounts
- Foreign exchange volatilityImpact: MediumLikelihood: High
Revenue and costs are spread across USD, ILS, EUR, and GBP, creating translation and transaction risk.
Exposure: Global operations and reporting
- Tariff and trade cost pressureImpact: MediumLikelihood: Medium
US-bound simulator sales are directly affected by tariffs and import-related costs.
Exposure: US hardware shipments
- Acquisition integrationImpact: Medium
Integrating acquired businesses can affect systems, product roadmaps, and operating execution.
Exposure: Purchased businesses and workforce
Accounting
Judgemental itemsDifferent delivery patterns can shift when revenue is recognized and affect quarterly comparability.
Impact: Software, hardware, and support contracts may be recognized at different times
Acquisitions create balance sheet assets that require impairment testing and assumption-based valuation.
Impact: Future write-downs could affect reported earnings and equity
The company reports in SEK but operates in multiple currencies, so exchange rates influence reported figures.
Impact: USD, ILS, EUR, and GBP exposure affects revenue and cost comparability
Employee warrant programs create IFRS 2 expenses over the vesting period.
Impact: Non-cash compensation affects operating profit and dilution
International offices create right-of-use assets and lease liabilities under IFRS 16.
Impact: Office footprint affects balance sheet and depreciation/interest expense
Similar listed companies
Publicly listed companies with a comparable business focus.
Getinge
GETI-B · Health Care
Getinge AB is a global provider of products and solutions for healthcare and life sciences, focusing on intensive care, cardiovascular procedures, operating…
Vicarious Surgical Inc.
RBOT · Orthopedic, Prosthetic & Surgical Appliances & Supplies
CellaVision
CEVI · Health Care
CellaVision is a global medical technology company specializing in the development and sale of advanced solutions for the routine analysis of blood and other body fluids.
Alphatec Holdings, Inc.
ATEC · Surgical & Medical Instruments & Apparatus
Carasent
CARA · Health Care
Carasent is a Swedish company specializing in digital services for the healthcare industry.
SEB
SEB-A · Financials
Saab AB is a Swedish high-technology company specializing in defense, aviation, and civil security.
Last updated: 24/09/2026